Metronidazole Bioassay
- 1 February 1976
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 9 (2) , 260-261
- https://doi.org/10.1128/aac.9.2.260
Abstract
Urine from patients receiving metronidazole [1-(2-hydroxyethyl)-2-methyl-5-nitromidazole] orally or per vagina were subjected to paper chromatographic fractionation and examined for anticlostridial activity. Unmodified metronidazole and several metabolites were detected. These findings indicate that the clostridial bioassay may be limited in its applicability to the study of the pharmacodynamics of metronidazole as it does not differentiate between the parent substance and some of its metabolites. Moreover, some of the latter, although they possess antibacterial activity, may not have antiprotozoan activity.Keywords
This publication has 9 references indexed in Scilit:
- Pharmacokinetics of Metronidazole as Determined by BioassayAntimicrobial Agents and Chemotherapy, 1974
- Metronidazole and amebiasisDigestive Diseases and Sciences, 1974
- Cutaneous leishmaniasis treated with metronidazole.1973
- Metronidazole versus anaerobes. In vitro data and initial clinical observations.1972
- Bactericidal Activity of Five Antimicrobial Agents against Bacteroides fragilisThe Journal of Infectious Diseases, 1972
- ISOLATION AND IDENTIFICATION OF URINARY OXIDATIVE METABOLITES OF METRONIDAZOLE IN MAN1968
- Isolation and identification of the major urinary metabolite of metronidazoleLife Sciences, 1967
- METRONIDAZOLE IN AMŒBIC DYSENTERY AND AMŒBIC LIVER ABSCESSThe Lancet, 1966
- [The activity of 1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole (R. P. 8823) against experimental Trichomonas vaginalis infections].1959